Cloning and mRNA tissue distribution of human PPARγ coactivator-1

Larrouy, D; Vidal, H; Andreelli, F; Laville, M; Langin, D
December 1999
International Journal of Obesity & Related Metabolic Disorders;Dec1999, Vol. 23 Issue 12, p1327
Academic Journal
OBJECTIVES: To determine human PPARγ coactivator-1 (PGC-1) amino acid sequence and to study PGC-1 mRNA tissue distribution. PGC-1 is a novel transcriptional coactivator of nuclear receptors that may play a role in the control of thermogenesis. SUBJECTS: Subcutaneous adipose tissue was obtained from six obese and five lean male subjects. Vastus lateralis skeletal muscle was obtained from seven lean and six obese subjects undergoing a 5-day severe calorie restriction. Other tissue biopsies were from nonobese nondiabetic subjects. METHODS: Human PGC-1 was cloned from a skeletal muscle cDNA library. A reverse transcription-competitive polymerase chain reaction assay was developed to determine PGC-1 mRNA levels in human tissues. RESULTS: The human amino acid sequence showed 95% identity with mouse PGC-1. PGC-1 mRNA was expressed at very low levels in the small and large intestines and white adipose tissue. Heart, kidney, liver and skeletal muscle showed higher mRNA levels. The degree of obesity did not affect PGC-1 mRNA levels in adipose tissue while lean subjects expressed more PGC-1 mRNA than obese subjects in skeletal muscle. A 5-day severe calorie restriction induced PGC-1 mRNA expression in skeletal muscle of obese but not of lean subjects. CONCLUSION: PGC-1 shows a restricted tissue expression that suggests a tissue-specific role in the control of gene transcription and possible interaction with various members of the PPAR family. The lower expression of skeletal muscle PGC-1 in obesity could contribute to an alteration of mitochondrial gene expression.


Related Articles

  • MBX-102/JNJ39659100, a Novel Non-TZD Selective Partial PPAR-? Agonist Lowers Triglyceride Independently of PPAR-a Activation. Chandalia, Apurva; Clarke, Holly J.; Clemens, L. Edward; Pandey, Bindu; Vicena, Vic; Lee, Paul; Lavan, Brian E.; Gregoire, Francine M. // PPAR Research;2009, Special section p1 

    MBX-102/JNJ-39659100 (MBX-102) is a selective, partial PPAR-? agonist that lowers glucose in the absence of some of the side effects, such as weight gain and edema, that are observed with the TZDs. Interestingly MBX-102 also displays pronounced triglyceride lowering in preclinical rodent models...

  • Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPAR?). O'Sullivan, Saoirse E.; Kendall, David A.; Randall, Michael D. // PPAR Research;2009, Special section p1 

    The aim of the present study was to examine whether endocannabinoids cause PPAR?-mediated vascular actions. Functional vascular studies were carried out in rat aortae. Anandamide and N-arachidonoyl-dopamine (NADA), but not palmitoylethanolamide, caused significant vasorelaxation over time (2...

  • PPARs and Xenobiotic-Induced Adverse Effects: Relevance to Human Health. Lau, Christopher; Abbott, Barbara D.; Corton, J. Christopher; Cunningham, Michael L. // PPAR Research;2010, p1 

    The article discusses various papers on peroxisome proliferator-activated receptors (PPARs) published within the issue including one on the mRNA and protein expression of PPAR subtypes, one on the role of PPARα in liver and skeletal muscle, and another on the use of antihyperlipidemic drugs.

  • PPARs and RXRs in Male and Female Fertility and Reproduction. Froment, P. // PPAR Research;2008 Special Issue 2, Special section p1 

    The article focuses on the role of peroxisome proliferator-activated receptors (PPARs) and retinoid X receptor (RXR) in fertility and reproduction. It notes the PPARs are ligand-activated nuclear receptors controlling several essential physiological processes, such as homeostasis, lipid, and...

  • Human peroxisome proliferator-activated receptor-gamma2. Vigouroux, Corinne; Fajas, Lluis; Khallouf, Eliane; Meier, Muriel; Gyapay, Gabor; Lascols, Olivier; Auwerx, Johan; Weissenbach, Jean; Capeau, Jacqueline; Magre, Jocelyne // Diabetes;Mar1998, Vol. 47 Issue 3, p490 

    Studies the peroxisome proliferator-activated receptor (PPAR)-gamma2 as a candidate gene in lipotrophic diabetes (LD), which is a rare recessive autosomic disorder characterized by a complete absence of adipose tissue. Identification of a single amino acid variant in the PPAR-gamma2-specific...

  • Toxicogenomic Dissection of the Perfluorooctanoic Acid Transcript Profile in Mouse Liver: Evidence for the Involvement of Nuclear Receptors PPAR{alpha} and CAR. Mitchell B. Rosen; Janice S. Lee; Hongzu Ren; Beena Vallanat; Jie Liu; Michael P. Waalkes; Barbara D. Abbott; Christopher Lau; J. Christopher Corton // Toxicological Sciences;May2008, Vol. 103 Issue 1, p46 

    A number of perfluorinated alkyl acids including perfluorooctanoic acid (PFOA) elicit effects similar to peroxisome proliferator chemicals (PPC) in mouse and rat liver. There is strong evidence that PPC cause many of their effects linked to liver cancer through the nuclear receptor peroxisome...

  • PPARs and Anticancer Therapies. Robbins, Michael E. C.; Linard, Christine; Panigrahy, Dipak // PPAR Research;2010, p1 

    The article discusses various papers published within the issue including one on the use of peroxisome proliferator-activated receptors (PPAR) γ and cyclooxygenase 2 as cancer prognostic marker, one on the response of differentiated melanoma cells to PPARγ and retinoid X receptor agonists,...

  • Promotion of Colon Tumors in C57BL/6J-APC min /+ Mice by Thiazolidinedione PPARγ Agonists and a Structurally Unrelated PPARγ Agonist. Pino, Michael V.; Kelley, Michael F.; Jayyosi, Zaid // Toxicologic Pathology;Jan/Feb2004, Vol. 32 Issue 1, p58 

    Thiazolidinedione PPARγ agonists (troglitazone and rosiglitazone) were previously shown to promote colon tumor formation in C57BL/6J-APC min /+ mice, a model for human familial adenomatous polyposis. This study was conducted to determine if another thiazolidinedione PPARγ agonist,...

  • DC-SCRIPT: Nuclear Receptor Modulation and Prognostic Significance in Primary Breast Cancer. Ansems, M.; Hontelez, S.; Looman, M. W. G.; Karthaus, N.; Bult, P.; Bonenkamp, J. J.; Jansen, J. H.; Sweep, F. C. G. J.; Span, P. N.; Adema, Gosse J. // JNCI: Journal of the National Cancer Institute;1/6/2010, Vol. 102 Issue 1, p54 

    Background: Nuclear receptors, including estrogen receptor (ER), progesterone receptor (PR)-B, peroxisome proliferator–activated receptor gamma, and retinoic acid receptor alpha, have been implicated in breast cancer etiology and progression. We investigated the role of dendritic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics